查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2088645

磁振造影血管血管造影術（MRA）市場：2026-2032年全球市場預測（按產品類型、技術、磁場強度、應用和最終用戶分類）

Magnetic Resonance Angiography Market by Product Type, Technology, Field Strength, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，磁振造影血管造影術(MRA) 市場將成長至 76.7 億美元，複合年成長率為 11.57%。

主要市場統計數據
基準年 2025 35.6億美元
預計年份：2026年 39.2億美元
預測年份 2032 76.7億美元
複合年成長率 (%) 11.57%

磁振造影血管血管造影術（MRA）市場簡介

磁振造影血管血管造影術（MRA）是一種專門的血管成像技術，它利用磁振造影（MRI）的物理原理，無需使用電離輻射即可顯示動脈和靜脈。 MRA可用於評估腦血管疾病、周邊動脈疾病、腎動脈狹窄、主動脈病變、先天性血管畸形、術前血管定位。在醫學領域，早期診斷和長期後續觀察的重要性日益凸顯，MRA作為一種非侵入性方法，其應用價值正在不斷提升，可替代或補充電腦斷層血管造影術（CTA）和導管血管造影術。

MRA領域的變革性變化

磁振造影血管攝影（MRA）領域正從以檢查為中心的影像方式轉向整合血管診療路徑。醫院和影像中心正利用MRA進行中風篩檢、動脈瘤評估、周邊血管評估和慢性血管疾病後續觀察，而放射科團隊則在尋求更快速的掃描方案，以提高掃描儀的處理能力，同時又不影響診斷的可靠性。

人工智慧對MRA的累積影響

人工智慧 (AI) 對磁振造影血管攝影 (MRA) 的各個階段都產生了累積的影響，從影像擷取和重建到影像解讀和工作流程最佳化。 AI 驅動的重建和降噪技術能夠縮短掃描時間並提高影像品質的穩定性。同時，自動化的血管分割、狹窄量化和異常檢測工具旨在提高放射科醫師的工作效率和診斷結果的可重複性。

磁振血管造影術（MRA）的關鍵區域見解

北美地區憑藉其成熟的磁振造影血管攝影（血管造影術）領域的領先地區。美國擁有高密度的專科醫生、綜合性中風中心和大規模大學醫院，而加拿大的公共醫療保健系統則能夠滿足中風、血管外科、腫瘤和慢性疾病等各個治療領域的需求。

針對東協、海灣合作理事會、歐盟、金磚國家、七國集團和北約的關鍵群體特定見解

在東協市場，尤其是在都市區，隨著公立醫院設施的升級和對私立診斷實驗室的投資，磁振造影（MRI）的普及程度正在提高。磁振造影血管攝影（MRA）的需求與心血管疾病風險上升、糖尿病盛行率增加、中風負擔加重以及對先進神經血管成像的需求密切相關，但保險報銷體係不均衡、掃描儀可用性不足以及放射科醫生短缺等問題仍然阻礙著MRA的普及。

主要國家引入MRA的趨勢

美國是全球最大、創新主導最強的磁振造影血管攝影（MRA）市場，這得益於學術放射學、認證卒中中心、血管外科計畫、廣泛的磁振造影（MRI）普及以及美國食品藥物管理局（FDA）對影像人工智慧（AI）的積極核准流程。加拿大的需求則受到公共資金支持的影像服務、各省投資週期以及中風、癌症和血管疾病治療路徑中的臨床優先事項的影響。同時，在墨西哥和巴西，私立醫院、連鎖診斷機構以及服務心血管代謝疾病負擔日益加重的都市區三級醫療機構發揮主導作用。

為行業領導者提供的實用建議

產業領導者應優先考慮更快速、更標準化的磁振造影血管攝影（MRA）方案，以提高掃描儀利用率並減少因患者移動而導致的重複掃描。供應商和醫療機構可以透過提供針對1.5T和3T磁振造影系統最佳化的神經血管、腎臟、主動脈和周邊血管成像方案庫來促進這些方案的採用。

調查方法

本執行摘要採用結構化的初級和二級研究框架編寫，結合了公開可用的證據和檢驗的市場分析。二級資訊來源包括監管資料庫、醫療保健出版刊物、放射學會指南、同行評審的醫學文獻、醫院採購趨勢、保險報銷參考資料和宏觀經濟醫療保健指標。

結論

隨著醫療保健系統對精準、非侵入性、無輻射的血管成像技術的需求日益成長，磁振造影血管造影術（MRA）預計將繼續保持其重要性。這種需求主要源於心血管和神經血管疾病的負擔、人口老化、追蹤影像的需求以及對磁振造影基礎設施的持續投入。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 磁振造影血管血管造影術（MRA）市場：依產品類型分類

  • 配件
    • 線圈
    • 注射器
    • 病患監測設備
  • MRA系統
  • 造影
    • 钆基造影劑
    • 氧化鐵奈米顆粒
  • 軟體

第8章 磁振造影血管血管造影術（MRA）市場：依技術分類

  • 使用造影劑的磁振造影血管攝影
    • 飛行時間（TOF）
    • 相襯（PC）
  • 不使用造影血管攝影（MRA）

第9章 磁振造影血管血管造影術（MRA）市場：依磁場強度分類

  • 低場磁振造影
  • 中場磁振造影
  • 高場磁振造影

第10章 磁振造影血管血管造影術（MRA）市場：依應用領域分類

  • 心臟及胸腔血管
    • 冠狀動脈成像
    • 主動脈影像
    • 肺動脈影像
  • 神經血管
    • 中風診斷
    • 動脈瘤的檢測
    • 頸動脈影像
  • 周邊血管
    • 下肢動脈
    • 上肢動脈
  • 腎臟血管造影術
  • 腹部影像

第11章 磁振造影血管血管造影術（MRA）市場：依最終用戶分類

  • 醫院
  • 學術和研究機構
  • 門診手術中心
  • 診斷影像中心

第12章 磁振造影血管血管造影術（MRA）市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章 磁振造影血管血管造影術（MRA）市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 磁振造影血管血管造影術（MRA）市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Agfa-Gevaert NV
  • Aspect Imaging Ltd.
  • Aurora Imaging Technology, Inc.
  • Bruker Corporation
  • Canon Medical Systems Corporation
  • Carestream Health, Inc.
  • CurveBeam AI, Inc.
  • Esaote SpA
  • FUJIFILM Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Hyperfine, Inc.
  • IMRIS Inc.
  • Koninklijke Philips NV
  • Mediso Ltd.
  • MR Solutions Ltd.
  • Nano-X Imaging Ltd.
  • Neusoft Medical Systems Co., Ltd.
  • Samsung Medison Co., Ltd.
  • Shenzhen Anke High-tech Co., Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • Synaptive Medical Inc.
  • Time Medical Systems Co., Ltd.
  • United Imaging Healthcare Co., Ltd.
Product Code: MRR-A339DAEFA1A0

The Magnetic Resonance Angiography Market is projected to grow by USD 7.67 billion at a CAGR of 11.57% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.56 billion
Estimated Year [2026] USD 3.92 billion
Forecast Year [2032] USD 7.67 billion
CAGR (%) 11.57%

Magnetic Resonance Angiography Market Introduction

Magnetic Resonance Angiography (MRA) is a specialized vascular imaging technique that uses MRI physics to visualize arteries and veins without ionizing radiation. It supports assessment of cerebrovascular disease, peripheral artery disease, renal artery stenosis, aortic pathology, congenital vascular anomalies, and pre-surgical vascular mapping. As healthcare systems prioritize earlier diagnosis and longitudinal monitoring, MRA is gaining relevance as a non-invasive alternative or complement to computed tomography angiography and catheter-based angiography.

The magnetic resonance angiography market is shaped by demand for high-quality vascular imaging, installed MRI capacity, clinical preference for radiation-free diagnostics, and innovation in contrast-enhanced and non-contrast MRA sequences. Adoption is strongest where advanced radiology infrastructure, trained MRI technologists, reimbursement pathways, and cardiovascular and neurovascular care networks are well established. According to the World Health Organization, cardiovascular diseases remain the leading cause of death globally, reinforcing the clinical need for accurate vascular imaging across acute care, chronic disease management, and interventional planning.

Transformative Shifts in the MRA Landscape

The MRA landscape is shifting from procedure-centered imaging toward integrated vascular care pathways. Hospitals and diagnostic imaging centers are using MRA for stroke workups, aneurysm evaluation, peripheral vascular assessment, and follow-up of chronic vascular conditions, while radiology teams seek faster protocols that improve scanner throughput without compromising diagnostic confidence.

Technology development is also changing competitive dynamics. Non-contrast MRA is becoming more important because it can reduce reliance on gadolinium-based contrast agents in patients with renal impairment or repeated imaging needs. At the same time, high-field MRI systems, advanced coils, parallel imaging, compressed sensing, and motion-correction techniques are improving image quality and shortening acquisition times, strengthening MRA's role in precision vascular imaging. These shifts align with broader healthcare priorities around radiation reduction, contrast-agent stewardship, value-based imaging, and standardized reporting for vascular disease.

Cumulative Impact of Artificial Intelligence in MRA

Artificial intelligence is having a cumulative impact across MRA acquisition, reconstruction, interpretation, and workflow orchestration. AI-enabled reconstruction and denoising can support shorter scan times and more consistent image quality, while automated vessel segmentation, stenosis quantification, and anomaly detection tools are designed to improve radiologist efficiency and reproducibility.

Regulatory activity confirms that AI is no longer experimental in medical imaging; the U.S. FDA maintains an expanding list of cleared AI-enabled medical devices, with radiology representing the largest category. For MRA, the most practical near-term value is expected in protocol optimization, triage of suspected vascular abnormalities, quantitative reporting, and integration with enterprise imaging systems, provided models are validated across scanner vendors, patient populations, and clinical settings. Successful deployment also depends on transparent performance monitoring, cybersecurity controls, interoperability with picture archiving and communication systems, and clinician oversight to minimize bias and preserve diagnostic accountability.

Key Regional Insights for Magnetic Resonance Angiography

North America remains a leading region for magnetic resonance angiography due to mature MRI infrastructure, strong neuroradiology and cardiovascular imaging capabilities, and established reimbursement mechanisms in the United States and Canada. The United States benefits from high specialist density, comprehensive stroke centers, and large academic medical centers, while Canada's publicly funded system supports demand through stroke, vascular surgery, oncology, and chronic disease pathways.

Europe shows broad adoption supported by universal or mixed healthcare systems, strong radiology societies, and advanced hospital networks across Germany, France, the United Kingdom, Italy, and Spain. The European Union's emphasis on medical device regulation, post-market surveillance, data protection, and evidence-based procurement also influences purchasing decisions, AI deployment, and contrast-agent stewardship. Russia continues to support MRA demand through large hospital systems and specialist diagnostic centers.

Asia-Pacific is a fast-evolving opportunity base as China, Japan, India, South Korea, Australia, and ASEAN countries expand MRI access, tertiary care capacity, and advanced diagnostics. Japan and South Korea benefit from high-technology healthcare environments, China is scaling high-end imaging infrastructure, India is expanding access in metropolitan and tier-2 cities, and Australia maintains strong use through public-private specialist referral networks. Latin America, led by Brazil and Mexico, shows momentum in private imaging networks and tertiary hospitals, while the Middle East benefits from healthcare modernization in GCC markets, hospital digitization, and investment in specialist care. Africa remains comparatively underpenetrated, with MRA demand concentrated in major urban hospitals, academic centers, and private diagnostic facilities where MRI availability and specialist interpretation are accessible.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN markets are expanding access to MRI through public hospital upgrades and private diagnostic investment, particularly in urban centers. Demand for MRA is tied to rising cardiovascular risk, diabetes prevalence, stroke burden, and the need for advanced neurovascular imaging, although uneven reimbursement, scanner availability, and radiologist workforce constraints continue to shape adoption.

The GCC is investing in tertiary care, medical tourism, and digital health infrastructure, making it a high-potential group for advanced MRI angiography systems and AI-enabled imaging workflows. The European Union prioritizes safety, interoperability, privacy, clinical evidence, and regulatory compliance, creating demand for validated MRA protocols, harmonized reporting, and AI solutions that meet medical device and data governance requirements.

BRICS countries represent a scale-driven opportunity, with China and India expanding diagnostic capacity, Brazil strengthening private imaging access, Russia maintaining specialized hospital networks, and South Africa serving as a regional hub for advanced tertiary care. G7 countries remain innovation leaders due to installed MRI capacity, academic research output, aging populations, and reimbursement maturity, while NATO countries benefit from broader healthcare and defense-linked requirements for trauma, vascular assessment, rehabilitation, and advanced imaging readiness.

Key Country Insights for MRA Adoption

The United States is the largest and most innovation-driven MRA market, supported by academic radiology, certified stroke centers, vascular surgery programs, broad MRI availability, and an active FDA pathway for imaging AI. Canada's demand is shaped by publicly funded imaging access, provincial investment cycles, and clinical prioritization of stroke, cancer, and vascular disease pathways, while Mexico and Brazil are led by private hospitals, diagnostic chains, and tertiary urban centers serving populations with growing cardiometabolic disease burden.

In Europe, the United Kingdom, Germany, France, Italy, and Spain maintain strong clinical use of MRA across neurovascular, aortic, renal, and peripheral vascular indications. Germany benefits from advanced imaging infrastructure and specialist hospital networks, France from centralized healthcare planning and strong clinical governance, and the United Kingdom from national pathways for stroke and vascular care. Italy and Spain support demand through public hospital systems and regional specialty centers, while Russia retains MRA utilization through large hospital systems, academic institutions, and specialist centers.

Asia-Pacific country dynamics are diverse. China is scaling high-end imaging capacity and domestic medical technology development, India is expanding MRI access in metropolitan and tier-2 cities, Japan has advanced MRI adoption and aging-related vascular demand, South Korea combines hospital digitization with high technology uptake, and Australia maintains strong demand through specialist referral networks and public-private healthcare delivery. Across these countries, MRA adoption is most closely linked to MRI availability, reimbursement clarity, subspecialty radiology capacity, stroke preparedness, and the ability to integrate advanced protocols into routine clinical workflows.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize faster, standardized MRA protocols that improve scanner utilization and reduce patient motion-related repeat scans. Vendors and providers can strengthen adoption by offering optimized protocol libraries for neurovascular, renal, aortic, and peripheral vascular imaging across 1.5T and 3T MRI systems.

Commercial strategies should emphasize non-contrast MRA capabilities, AI-assisted workflow tools, and evidence demonstrating diagnostic performance, patient safety, and operational efficiency. Partnerships with academic medical centers, stroke networks, vascular surgery departments, and cloud-based imaging platforms can accelerate validation, implementation, and clinical acceptance.

Executives should also align product development with regulatory expectations, cybersecurity requirements, data protection rules, and interoperability standards. In emerging markets, financing models, radiographer training, service uptime, remote reading partnerships, and structured education for referring clinicians can be as important as scanner specifications in driving sustainable adoption.

Research Methodology

This executive summary is developed using a structured secondary and primary research framework, combining publicly available evidence with validated market interpretation. Secondary sources include regulatory databases, healthcare agency publications, radiology society guidance, peer-reviewed medical literature, hospital procurement signals, reimbursement references, and macroeconomic healthcare indicators.

The methodology evaluates magnetic resonance angiography across technology type, contrast use, clinical application, end user, geography, and competitive positioning without relying on market estimation, market sizing, market share, or forecasting. Insights are triangulated through source validation, trend comparison, and consistency checks against established clinical practice, including guidance from organizations such as the FDA, EMA, ACR, RSNA, OECD, and WHO where relevant.

Conclusion

Magnetic Resonance Angiography is positioned for sustained relevance as healthcare systems seek accurate, non-invasive, and radiation-free vascular imaging. Demand is supported by cardiovascular and neurovascular disease burden, aging populations, the need for follow-up imaging, and continued investment in MRI infrastructure.

The next phase of adoption will be defined by faster acquisition, non-contrast techniques, AI-enabled reconstruction and interpretation, and region-specific access strategies. Organizations that combine clinical evidence, operational efficiency, regulatory compliance, and interoperable digital integration will be best positioned to lead in the evolving MRA market.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Magnetic Resonance Angiography Market, by Product Type

  • 7.1. Accessories
    • 7.1.1. Coils
    • 7.1.2. Injectors
    • 7.1.3. Patient Monitoring Devices
  • 7.2. MRA Systems
  • 7.3. Contrast Agents
    • 7.3.1. Gadolinium-based Agents
    • 7.3.2. Iron Oxide Nanoparticles
  • 7.4. Software

8. Magnetic Resonance Angiography Market, by Technology

  • 8.1. Contrast Enhanced MRA
    • 8.1.1. Time-of-Flight (TOF)
    • 8.1.2. Phase Contrast (PC)
  • 8.2. Non Contrast Enhanced MRA

9. Magnetic Resonance Angiography Market, by Field Strength

  • 9.1. Low Field MRI
  • 9.2. Mid Field MRI
  • 9.3. High Field MRI

10. Magnetic Resonance Angiography Market, by Application

  • 10.1. Cardiac & Thoracic Vessels
    • 10.1.1. Coronary Artery Imaging
    • 10.1.2. Aortic Imaging
    • 10.1.3. Pulmonary Artery Imaging
  • 10.2. Neurovascular
    • 10.2.1. Stroke Diagnosis
    • 10.2.2. Aneurysm Detection
    • 10.2.3. Carotid Artery Imaging
  • 10.3. Peripheral Vascular
    • 10.3.1. Lower Extremity Arteries
    • 10.3.2. Upper Extremity Arteries
  • 10.4. Renal Angiography
  • 10.5. Abdomen Imaging

11. Magnetic Resonance Angiography Market, by End User

  • 11.1. Hospitals
  • 11.2. Academic & Research Institute
  • 11.3. Ambulatory Surgical Centers
  • 11.4. Diagnostic Imaging Centers

12. Magnetic Resonance Angiography Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Magnetic Resonance Angiography Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Magnetic Resonance Angiography Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Agfa-Gevaert N.V.
  • 16.2. Aspect Imaging Ltd.
  • 16.3. Aurora Imaging Technology, Inc.
  • 16.4. Bruker Corporation
  • 16.5. Canon Medical Systems Corporation
  • 16.6. Carestream Health, Inc.
  • 16.7. CurveBeam AI, Inc.
  • 16.8. Esaote S.p.A.
  • 16.9. FUJIFILM Holdings Corporation
  • 16.10. GE HealthCare Technologies Inc.
  • 16.11. Hyperfine, Inc.
  • 16.12. IMRIS Inc.
  • 16.13. Koninklijke Philips N.V.
  • 16.14. Mediso Ltd.
  • 16.15. MR Solutions Ltd.
  • 16.16. Nano-X Imaging Ltd.
  • 16.17. Neusoft Medical Systems Co., Ltd.
  • 16.18. Samsung Medison Co., Ltd.
  • 16.19. Shenzhen Anke High-tech Co., Ltd.
  • 16.20. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 16.21. Shimadzu Corporation
  • 16.22. Siemens Healthineers AG
  • 16.23. Synaptive Medical Inc.
  • 16.24. Time Medical Systems Co., Ltd.
  • 16.25. United Imaging Healthcare Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ACCESSORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ACCESSORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL COILS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL COILS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL COILS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL INJECTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL INJECTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL INJECTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PATIENT MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PATIENT MONITORING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PATIENT MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MRA SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MRA SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MRA SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CONTRAST AGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CONTRAST AGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CONTRAST AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL GADOLINIUM-BASED AGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL GADOLINIUM-BASED AGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL GADOLINIUM-BASED AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL IRON OXIDE NANOPARTICLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL IRON OXIDE NANOPARTICLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL IRON OXIDE NANOPARTICLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CONTRAST ENHANCED MRA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CONTRAST ENHANCED MRA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CONTRAST ENHANCED MRA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL TIME-OF-FLIGHT (TOF) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL TIME-OF-FLIGHT (TOF) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL TIME-OF-FLIGHT (TOF) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PHASE CONTRAST (PC) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PHASE CONTRAST (PC) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PHASE CONTRAST (PC) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NON CONTRAST ENHANCED MRA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NON CONTRAST ENHANCED MRA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NON CONTRAST ENHANCED MRA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL LOW FIELD MRI MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL LOW FIELD MRI MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL LOW FIELD MRI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MID FIELD MRI MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MID FIELD MRI MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MID FIELD MRI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HIGH FIELD MRI MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HIGH FIELD MRI MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HIGH FIELD MRI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CARDIAC & THORACIC VESSELS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CARDIAC & THORACIC VESSELS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CARDIAC & THORACIC VESSELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CORONARY ARTERY IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CORONARY ARTERY IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CORONARY ARTERY IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL AORTIC IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL AORTIC IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL AORTIC IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PULMONARY ARTERY IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PULMONARY ARTERY IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PULMONARY ARTERY IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL NEUROVASCULAR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL NEUROVASCULAR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL NEUROVASCULAR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL STROKE DIAGNOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL STROKE DIAGNOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ANEURYSM DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ANEURYSM DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ANEURYSM DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CAROTID ARTERY IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CAROTID ARTERY IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CAROTID ARTERY IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PERIPHERAL VASCULAR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PERIPHERAL VASCULAR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PERIPHERAL VASCULAR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL LOWER EXTREMITY ARTERIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL LOWER EXTREMITY ARTERIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL LOWER EXTREMITY ARTERIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL UPPER EXTREMITY ARTERIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL UPPER EXTREMITY ARTERIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL UPPER EXTREMITY ARTERIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL RENAL ANGIOGRAPHY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL RENAL ANGIOGRAPHY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL RENAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ABDOMEN IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ABDOMEN IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ABDOMEN IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ACADEMIC & RESEARCH INSTITUTE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ACADEMIC & RESEARCH INSTITUTE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ACADEMIC & RESEARCH INSTITUTE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL DIAGNOSTIC IMAGING CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL DIAGNOSTIC IMAGING CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL DIAGNOSTIC IMAGING CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST AGENTS, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED MRA, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC & THORACIC VESSELS, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST AGENTS, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED MRA, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC & THORACIC VESSELS, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST AGENTS, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED MRA, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC & THORACIC VESSELS, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST AGENTS, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED MRA, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC & THORACIC VESSELS, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST AGENTS, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED MRA, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC & THORACIC VESSELS, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST AGENTS, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED MRA, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC & THORACIC VESSELS, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST AGENTS, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED MRA, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC & THORACIC VESSELS, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. GCC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 193. GCC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. GCC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 195. GCC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST AGENTS, 2018-2032 (USD MILLION)
  • TABLE 196. GCC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 197. GCC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED MRA, 2018-2032 (USD MILLION)
  • TABLE 198. GCC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 199. GCC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. GCC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC & THORACIC VESSELS, 2018-2032 (USD MILLION)
  • TABLE 201. GCC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 202. GCC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 203. GCC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST AGENTS, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED MRA, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC & THORACIC VESSELS, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST AGENTS, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED MRA, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC & THORACIC VESSELS, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. G7 MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 229. G7 MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. G7 MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 231. G7 MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST AGENTS, 2018-2032 (USD MILLION)
  • TABLE 232. G7 MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 233. G7 MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED MRA, 2018-2032 (USD MILLION)
  • TABLE 234. G7 MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 235. G7 MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 236. G7 MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC & THORACIC VESSELS, 2018-2032 (USD MILLION)
  • TABLE 237. G7 MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 238. G7 MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 239. G7 MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 240. NATO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 241. NATO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. NATO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 243. NATO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST AGENTS, 2018-2032 (USD MILLION)
  • TABLE 244. NATO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 245. NATO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED MRA, 2018-2032 (USD MILLION)
  • TABLE 246. NATO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 247. NATO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 248. NATO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC & THORACIC VESSELS, 2018-2032 (USD MILLION)
  • TABLE 249. NATO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 250. NATO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 251. NATO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED STATES MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST AGENTS, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED STATES MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED MRA, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC & THORACIC VESSELS, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 265. CANADA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 266. CANADA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. CANADA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 268. CANADA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST AGENTS, 2018-2032 (USD MILLION)
  • TABLE 269. CANADA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 270. CANADA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED MRA, 2018-2032 (USD MILLION)
  • TABLE 271. CANADA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 272. CANADA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 273. CANADA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC & THORACIC VESSELS, 2018-2032 (USD MILLION)
  • TABLE 274. CANADA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 275. CANADA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 276. CANADA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 277. MEXICO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 278. MEXICO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. MEXICO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 280. MEXICO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST AGENTS, 2018-2032 (USD MILLION)
  • TABLE 281. MEXICO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 282. MEXICO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED MRA, 2018-2032 (USD MILLION)
  • TABLE 283. MEXICO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 284. MEXICO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 285. MEXICO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC & THORACIC VESSELS, 2018-2032 (USD MILLION)
  • TABLE 286. MEXICO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 287. MEXICO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 288. MEXICO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 289. BRAZIL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 290. BRAZIL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 291. BRAZIL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 292. BRAZIL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST AGENTS, 2018-2032 (USD MILLION)
  • TABLE 293. BRAZIL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 294. BRAZIL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED MRA, 2018-2032 (USD MILLION)
  • TABLE 295. BRAZIL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 296. BRAZIL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 297. BRAZIL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC & THORACIC VESSELS, 2018-2032 (USD MILLION)
  • TABLE 298. BRAZIL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 299. BRAZIL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 300. BRAZIL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 301. UNITED KINGDOM MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 302. UNITED KINGDOM MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 303. UNITED KINGDOM MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 304. UNITED KINGDOM MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST AGENTS, 2018-2032 (USD MILLION)
  • TABLE 305. UNITED KINGDOM MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 306. UNITED KINGDOM MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED MRA, 2018-2032 (USD MILLION)
  • TABLE 307. UNITED KINGDOM MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 308. UNITED KINGDOM MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 309. UNITED KINGDOM MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC & THORACIC VESSELS, 2018-2032 (USD MILLION)
  • TABLE 310. UNITED KINGDOM MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 311. UNITED KINGDOM MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 312. UNITED KINGDOM MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 313. GERMANY MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 314. GERMANY MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 315. GERMANY MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 316. GERMANY MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST AGENTS, 2018-2032 (USD MILLION)
  • TABLE 317. GERMANY MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 318. GERMANY MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED MRA, 2018-2032 (USD MILLION)
  • TABLE 319. GERMANY MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 320. GERMANY MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 321. GERMANY MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC & THORACIC VESSELS, 2018-2032 (USD MILLION)
  • TABLE 322. GERMANY MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 323. GERMANY MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 324. GERMANY MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 325. FRANCE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 326. FRANCE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 327. FRANCE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 328. FRANCE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST AGENTS, 2018-2032 (USD MILLION)
  • TABLE 329. FRANCE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 330. FRANCE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED MRA, 2018-2032 (USD MILLION)
  • TABLE 331. FRANCE MAGNETIC RESON